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Abstract BMP4 loss-of-function mutations and deletions
have been shown to be associated with ocular, digital, and
brain anomalies, but due to the paucity of these reports, the
full phenotypic spectrum of human BMP4 mutations is not
clear. We screened 133 patients with a variety of ocular
disorders for BMP4 coding region mutations or genomic
deletions. BMP4 deletions were detected in two patients: a
patient affected with SHORT syndrome and a patient with
anterior segment anomalies along with craniofacial dys-
morphism and cognitive impairment. In addition to this,
three intragenic BMP4 mutations were identiﬁed. A patient
with anophthalmia, microphthalmia with sclerocornea,
right-sided diaphragmatic hernia, and hydrocephalus was
found to have a c.592C[T (p.R198X) nonsense mutation in
BMP4. A frameshift mutation, c.171dupC (p.E58RfsX17),
was identiﬁed in two half-siblings with anophthalmia/
microphthalmia, discordant developmental delay/postaxial
polydactyly, and poor growth as well as their unaffected
mother; one affected sibling carried an additional BMP4
mutation in the second allele, c.362A[G (p.H121R). This
is the ﬁrst report indicating a role for BMP4 in SHORT
syndrome, Axenfeld–Rieger malformation, growth delay,
macrocephaly, and diaphragmatic hernia. These results
signiﬁcantly expand the number of reported loss-of-func-
tion mutations, further support the critical role of BMP4 in
ocular development, and provide additional evidence of
variable expression/non-penetrance of BMP4 mutations.
Introduction
Bone morphogenetic protein 4 (BMP4) is a member of a
large cytokine family related to the transforming growth
factor-beta proteins. Bmp4 is an important regulator of
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when mutated or misexpressed in vertebrates (Chang et al.
2001; Furuta and Hogan 1998; Hogan 1996; Jiao et al.
2003; Solnica-Krezel 1999).
In humans, disruption of BMP4 by deletion or mutation
was shown to be associated with ocular, digital, and brain
anomalies. BMP4 is located at chromosome 14q22–q23,
near the OTX2 gene, which is a well-established cause of
anophthalmia/microphthalmia (Ragge et al. 2005; Schilter
et al. 2010). Deletion of BMP4 was ﬁrst demonstrated in
combination with OTX2 deletion in three patients with
anophthalmia, pituitary defects, developmental delay, and
structural brain anomalies with syndactyly, brachydactyly,
and genitourinary anomalies in one (Bakrania et al. 2008;
Nolen et al. 2006). A patient with de novo deletion of
BMP4 but not OTX2 was subsequently reported with
congenital glaucoma and sclerocornea, postaxial polysyn-
dactyly, brain anomalies, and developmental delay
(Hayashi et al. 2008). Two families with anophthalmia/
microphthalmia and intragenic mutations in BMP4 have
been identiﬁed (Bakrania et al. 2008). The ﬁrst mutation,
c.226delAG (p.S76CfsX29), was identiﬁed in a proband
with unilateral anophthalmia and coloboma, retinal dys-
trophy, and small anterior segment of the contralateral eye,
along with postaxial polydactyly, structural brain anoma-
lies, and learning difﬁculties. The c.226delAG mutation
was seen in three additional family members affected with
high myopia and/or polydactyly. The second, c.278A[G
(p.E93G), was identiﬁed in a proband with bilateral
microphthalmia, broad hands with low-placed thumbs,
brain anomalies, and developmental delay. The p.E93G
mutation was inherited from the father, whose only
anomaly was mild inferior pigmentation of both retinas. A
third variant in BMP4, c.751C[T (p.H251Y), was detected
in a proband with mild microphthalmia (corneal diameter
10.7 mm; axial length 20.2 mm) and anterior segment
anomalies as well as his unaffected brother (Zhang et al.
2009). The role of BMP4 in anterior segment development/
glaucoma is further supported by animal studies demon-
strating anterior segment dysgenesis and elevated intraoc-
ular pressure in Bmp4
?/- mice and defects in BMP4
signaling in experimental glaucoma models (Chang et al.
2001; Wordinger et al. 2007).
In addition to ocular phenotypes, BMP4 was shown to
be associated with cleft lip and palate (Suzuki et al. 2009),
renal malformations (Weber et al. 2008), and colorectal
cancer (Lubbe et al. 2011). Heterozygous missense muta-
tions in BMP4 were identiﬁed in seven probands with
subepithelial, microform, and overt cleft lip/palate, and a
nonsense mutation, p.R198X, was identiﬁed in another
proband with overt cleft lip and palate; no information was
provided regarding presence or absence of additional
anomalies in these patients. All of the missense mutations
were inherited from either mildly affected (three cases) or
unaffected parents (four cases); inheritance of the nonsense
mutation was not examined (Suzuki et al. 2009). Hetero-
zygous missense mutations in BMP4 were also identiﬁed in
four probands with renal agenesis, dysplasia, or hypoplasia,
and a homozygous missense mutation was seen in one
proband with cystic dysplasia of the kidneys; again, no
details were provided regarding presence or absence of
additional anomalies. Three of the mutations were inher-
ited from unaffected parents (including both parents of the
homozygous case): one was de novo, and the parents were
not tested in the remaining two cases (Weber et al. 2008).
Finally, BMP4 coding region variants were identiﬁed in six
probands with colorectal cancer in a case/control mutation
screen (Lubbe et al. 2011). Based on in silico analysis and
control data, the authors classiﬁed two missense and one
nonsense (p.R286X) variants as pathogenic mutations; no
inheritance pattern analysis was performed, and no addi-
tional systemic anomalies were documented for any of
these cases (Lubbe et al. 2011).
We present results from screening of BMP4 in patients
with various ocular conditions. Five new deletions/muta-
tions in BMP4 were found in four families. Our screening
identiﬁed two deletions of BMP4 but not OTX2, including
one in a patient with SHORT syndrome, one nonsense
mutation, and one frameshift mutation which was detected
in two half-siblings with discordant phenotypes with an
additional missense mutation in one.
Materials and methods
This human study was approved by the Institutional
Review Boards of Children’s Hospital of Wisconsin, the
University of Michigan, and Albert Einstein Healthcare
Network with written informed consent obtained from
every subject. Genomic DNA was extracted using standard
procedures from blood or buccal samples. Complete
sequence of the BMP4 coding region (reference sequence
NM_001202.3) was obtained for 133 patients including 60
with anophthalmia/microphthalmia (34 syndromic), 38
anterior segment disorders (29 syndromic) including 3
with SHORT syndrome, 16 cataracts, 4 coloboma, 5
high myopia, and 10 other disorders using the following
primers: set 1 forward, cttgatctttctgacctgct, and reverse,
ttcttggaggtaagcagctc, PCR product equal 656 bp and set 2
forward, attgcccaaccctgagctat, and reverse, ccagcta-
taaggaagcagtc, PCR product equal 1,069 bp. Patients with
a genetic etiology identiﬁed in previously reported and
unreported screens were excluded. Sequences were
reviewed manually and using Mutation Surveyor (Soft-
Genetics, State College, PA, USA). All mutations were
conﬁrmed by independent sequencing reactions using new
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123PCR products. Screening for deletions of BMP4 was per-
formed using Affymetrix Genome-Wide Human SNP
Array 6.0 or TaqMan assays in 89 of the above patients,
including 40 patients with anophthalmia/microphthalmia
and 26 with anterior segment disorders. In addition, all
deletions were conﬁrmed using TaqMan assays [BMP4
probes Hs02617539_cn (50) and Hs00282899_cn (30) that
recognize sequences located within the BMP4 ﬁrst and last
exons, respectively, and OTX2 probe Hs01323383_cn
designed against OTX2 exon 3 (ﬁrst coding exon)
sequence]. In order to determine the orientation of the
BMP4 mutations identiﬁed in Patient 5, PCR product
obtained with set 1 primers and the patient’s DNA was
cloned into pCRII-TOPO vector (Invitrogen, Carlsbad, CA,
USA) followed by DNA sequencing of nine independent
clones corresponding to single BMP4 alleles.
A total of 179 Caucasian, 89 African American, 91
Asian, and 93 Hispanic controls described previously (Reis
et al. 2010) were screened for mutations in BMP4.
Results
A deletion of BMP4 was detected in two unrelated patients
(Patients 1 and 2), a nonsense mutation was detected in a
third patient (Patient 3), and a frameshift mutation was
detected in a pair of affected half-siblings (Patients 4 and 5)
with an additional missense mutation in one (Patient 5).
The previously reported c.455T[C (p.V152A) polymor-
phism was also seen in cases and controls.
Patient 1 (Fig. 1a–c; Table 1) is a 6-year-old Caucasian
female with a diagnosis of SHORT syndrome. Her ocular
features include Rieger anomaly, congenital glaucoma,
microcornea, and nystagmus. She has short stature, poor
weight gain, and macrocephaly with measurements of
106.4 cm (3rd centile), 14.9 kg (\3rd centile), and 55 cm
([95th centile), respectively. The patient also has hyper-
extensible joints, delayed eruption of teeth (ﬁrst teeth
appeared at nearly 2 years of age), decreased subcutaneous
fat in upper trunk and head, and dysmorphic facial features
including prominent forehead, sunken eyes, small chin, and
hypoplastic nares. Hearing is normal; hands and feet appear
small with normal structure. Umbilicus is described as ‘a
bit pouchy’ with mildly increased skin. She has a history of
mildly delayed motor milestones felt to be related to her
joint hypermobility; she currently receives special educa-
tion services related to attention deﬁcit hyperactivity dis-
order and vision problems. Brain magnetic resonance
imaging (MRI) showed normal structures. Peripheral blood
chromosomes showed 46,XX (580 bands); previous
screening of PITX2 showed normal sequence and copy
number (data not shown). The patient was found to have a
2,263-kb deletion (1,508 probes in haploid state; minimum
interval chr14: 51,402,258–53,665,008; maximum interval
chr14: 51,400,039–53,667,259; based on UCSC 2006 hg18
assembly) of 14q22.1–14q22.2 which deletes one copy of
BMP4 as well as GNG2, NID2, C14orf166, PTGDR,
PTGER2, TXNDC16, GPR137C, ERO1L, PSMC6, STYX,
GCPNAT1, PLEKHC1, and DDHD1 (Fig. 2a). BMP4 is
the most distal gene included in the deletion, but the
deletion extends past the end of the coding region of
BMP4. Quantitative PCR data obtained with TaqMan
probes conﬁrmed deletion of one copy of BMP4 (Fig. 2b)
and presence of both copies of OTX2 (data not shown). The
mother (noted to have high myopia but otherwise normal
ocular and other systemic features) was tested by TaqMan
assay and showed no evidence of BMP4 deletion; the
unaffected father is not available for testing.
Patient 2 (Fig. 1d; Table 1) is a 12-year-old Caucasian
female with right corectopia, bilateral microphthalmia,
bilateral persistence of the pupillary membrane, high
myopia, strabismus, and nystagmus. The patient also has a
history of hypotonia and mild–moderate cognitive impair-
ment. The patient has dysmorphic facial features including
maxillary hypoplasia with midface ﬂattening, thin upper
lip, broad nasal bridge and tip, telecanthus, and had a
preauricular ear tag on the right. She has normal growth,
head circumference, umbilicus, hands, and feet. Head
imaging studies are not available. Peripheral blood chro-
mosome analysis showed 46, XX (550 bands), and subt-
elomeric FISH was normal. The patient is adopted, so
information about family history is limited, and no family
members are available for testing. The patient was found to
have a 158-kb deletion (122 probes in haploid state; min-
imum interval chr14:53,361,728–53,520,165; maximum
interval chr14:53,352,059–53,520,859; based on UCSC
2006 hg18 assembly) involving 14q22.2 which deletes one
copy of BMP4 (Fig. 2a). No other genes are present in the
deleted region. Quantitative PCR data obtained with Taq-
Man probes conﬁrmed deletion of one copy of BMP4
(Fig. 2b) and presence of both copies of OTX2 (data not
shown).
Patient 3 (Fig. 1e; Table 1) is a 19-month-old Caucasian
male with right anophthalmia/severe microphthalmia, left
mild microphthalmia with sclerocornea, facial asymmetry,
and right-sided diaphragmatic hernia. His height and
weight were normal at 11 weeks of age (60.4 cm/25th–
50th centile and 6.8 kg/75th–90th centile, respectively),
and by 19 months he was large for his age (90 cm/[97th
centile and 13.3 kg/75th–90th centile). He has mild–mod-
erate laryngomalacia with indentation from the innominate
artery and bilateral inguinal hernias. He is developmentally
normal with some minimal correction for his vision deﬁ-
cits. He has macrocephaly (43.5 cm at 11 weeks/ 90th–
97th centile; 51 cm at 19 months/ [97th centile), a large
anterior fontanelle, and hydrocephalus treated with a
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123subdural-peritoneal shunt. Brain MRI at 4 months of age
conﬁrmed the ocular ﬁndings and showed macrocrania
with very prominent subarachnoid spaces, superimposed
overlying subdural collections as well as diffuse cerebral
atrophy with ventricular prominence. Clinical chromo-
somal microarray (using Affymetrix Whole Genome-
Human SNP Array 6.0) was normal. He was found to have
a heterozygous c.592C[T (p.R198X) mutation, previously
reported in cleft lip/palate (Suzuki et al. 2009) and pre-
dicted to result in premature termination of the BMP4
protein (Fig. 3a). Neither parent carries the mutation.
Patient 4 (Fig. 1f; Table 1) is a 3.5-year-old Caucasian
female with bilateral clinical anophthalmia, small ears, and
a small left renal cyst. Her birthweight was 3.35 kg (25th–
50th centile), birth length was 49.5 cm (50th centile), and
birth head circumference was 34 cm (50th centile). At
36 months, her weight was 11 kg (\3rd centile), and height
was 93 cm (25th–50th centile). She has normal develop-
ment, craniofacial features, hands, and feet. Head CT in the
neonatal period showed signiﬁcantly small globes, minimal
ocular tissue, and absent optic nerves but otherwise normal
brain structures. She was found to have a heterozygous
c.171dupC (p.E58RfsX17) mutation (Fig. 3a).
Her 9-year-old maternal half-sister, Patient 5 (Fig. 1g;
Table 1), is affected with unilateral anophthalmia (left),
blepharophimosis and telecanthus and bilateral postaxial
polydactyly of both hands. Her birthweight was 2.72 kg
(25th centile), her length was 48 cm (25th centile), and her
head circumference was 34 cm (50th centile). At 9 years,
she demonstrates poor growth with height and weight\3rd
centile (121 cm and 20 kg) and relative macrocephaly
(75th centile) with frontal bossing. Her development is
appropriate for age. Head CT showed atrophic left globe
and small left orbit. Patient 5 was found to carry the same
heterozygous c.171dupC (p.E58RfsX17) mutation along
with a second variant, c.362A[G (p.H121R), in BMP4
(Fig. 3a, b). This variant was found to alter a conserved
amino acid (Fig. 3b) and is predicted to be tolerated by
SIFT (Ng and Henikoff 2003; http://sift.jcvi.org/) while
probably damaging by PolyPhen-2 (Adzhubei et al. 2010;
http://genetics.bwh.harvard.edu/pph2/) analysis. Both the
p.E58RfsX17 and p.H121R mutations affect exon 2 of
BMP4 and were determined to be positioned on different
alleles by PCR cloning and DNA sequencing of isolated
alleles. The unaffected mother of Patients 4 and 5 was
found to carry the p.E58RfsX17 mutation with no evidence
of mosaicism (data not shown); the mutation apparently
occurred de novo since the unaffected maternal grandpar-
ents of Patients 4 and 5 were found to carry wild-type
BMP4 alleles. The unaffected father of Patient 5 was not
available for testing. Neither parent was available for for-
mal ophthalmological examination, so mild ocular anom-
alies could not be ruled out.
Screening of 179 Caucasian, 89 African American, 91
Asian, and 93 Hispanic control individuals did not identify
any of the three coding region mutations discussed above.
Fig. 1 Patient 1 with SHORT
syndrome demonstrating short
stature, macrocephaly,
decreased subcutaneous fat in
upper trunk and head, prominent
forehead, sunken eyes, small
chin, and hypoplastic nares
(a) along with Rieger anomaly,
congenital glaucoma, and
microcornea (b, c). Patient 2
with bilateral microphthalmia,
maxillary hypoplasia with
midface ﬂattening, thin upper
lip, broad nasal bridge and tip,
and telecanthus (d). Patient 3
with right anophthalmia/severe
microphthalmia, left mild
microphthalmia with
sclerocornea, facial asymmetry
macrocephaly (e). Patient 4 with
bilateral clinical anophthalmia
(f) and Patient 5 with left
anophthalmia (prosthesis in
place) (g)
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This is the ﬁrst report of BMP4 deletion in a patient
with the complete constellation of features comprising
SHORT syndrome (Patient 1). SHORT syndrome was ﬁrst
described in 1975 and is characterized by Short stature,
hyperextensibility of joints or inguinal Hernia, ocular
depression, Rieger anomaly, and delay in dental eruption
(Teeth) (Gorlin et al. 1975; Sensenbrenner et al. 1975).
Autosomal dominant inheritance has been suggested
(Koenig et al. 2003), but the genetic basis of SHORT syn-
drome is currently poorly understood. One case report
identiﬁed a familial translocation, t(1;4)(q31.2;q25), pre-
sumably disrupting the PITX2 locus, in a child with SHORT
syndrome and his mother with Axenfeld–Rieger syndrome
and polycystic ovary syndrome (Karadeniz et al. 2004), but
no other studies have replicated involvement of PITX2 in
SHORT syndrome, which was also excluded in Patient 1 in
this study.
Since the patient with SHORT syndrome (Patient 1) is
affected with a deletion of the BMP4 region, we compared
the ‘‘SHORT’’ deletion with other patient deletions of this
region. Both BMP4 deletions reported in this study are
smaller than the previously reported deletion of BMP4
without OTX2 involvement (Hayashi et al. 2008). Patient 2
(reported in this manuscript) with deletion of BMP4 only
and the previously reported patient with a 2.7-Mb deletion
involving BMP4 (Hayashi et al. 2008) did not demonstrate
a SHORT syndrome phenotype. There are seven genes
which are deleted in Patient 1 with SHORT syndrome, but
not in Patient 2 or the patient presented by Hayashi et al.
(2008): GNG2, NID2, C14orf166, PTGDR, PTGER2,
Fig. 2 Affymetrix Genome-
Wide Human SNP Array 6.0
microarray analysis (a) and
TaqMan assay data (b) for
Patients 1 and 2. Heterozygous
BMP4 deletions (arrows in
a and b) were detected. The
UCSC Genome Browser
(http://genome.ucsc.edu) view
of the deleted region indicating
positions of genes is shown with
rectangular bars indicating the
extent of the deletion in each
patient
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123TXNDC16, and GPR137C. Although none of these genes
represents an obvious candidate for the observed phenotype
based on current data (http://www.ncbi.nlm.nih.gov/omim),
SHORT syndrome may be a contiguous gene deletion syn-
drome which requires deletion of one (or more) of these
genes in addition to BMP4.
Analysis of other phenotypic information presented in
this manuscript as well as previously reported data further
supports the role of BMP4 in SHORT syndrome. The
association of BMP4 with anterior segment dysgenesis
(Patients 2 and 3; Chang et al. 2001; Hayashi et al. 2008;
Zhang et al. 2009), poor growth with height and/or weight
measurements below the 3rd percentile (Patients 4 and 5;
Hayashi et al. 2008), macrocephaly (Patients 3 and 5) and
craniofacial/dental development in human patients (Patient
2; Suzuki et al. 2009) and animal models (Fujimori et al.
2010; Vainio et al. 1993; Zhang et al. 2000) is consistent
with features of SHORT syndrome. The fact that other
patients with BMP4 deletions/mutations do not demon-
strate the full SHORT syndrome phenotype may be
explained by variable phenotypic expressivity of BMP4
mutations and modiﬁcation of their effect(s) by other
genetic factors located elsewhere in genome. The observed
incomplete penetrance/variable expressivity of BMP4
mutations and their wide phenotypic spectrum are in
agreement with this possibility (Bakrania et al. 2008;
Lubbe et al. 2011; Suzuki et al. 2009; Weber et al. 2008;
Zhang et al. 2009). Screening of additional patients with
SHORT syndrome is needed to determine the role/fre-
quency of BMP4 mutations in this phenotype; in our study,
one out of three patients diagnosed with this rare condition
demonstrated BMP4 deletion.
The BMP4-positive phenotypes reported in this manu-
script also show overlap with the Axenfeld–Rieger spec-
trum (Alward 2000; Rieger 1934, 1935; Shields et al. 1985)
caused by mutations in the PITX2 and FOXC1 genes
(Semina et al. 1996;T u ¨mer and Bach-Holm 2009). This
spectrum is characterized by ocular ﬁndings that include
posterior embryotoxon, hypoplastic iris, irido-corneal
adhesions and glaucoma and additional systemic defects
such as craniofacial dysmorphism, dental hypoplasia and
redundant periumbilical skin. Patient 1 (SHORT syn-
drome) has the characteristic Rieger anomaly in combi-
nation with atypical dental and umbilical anomalies,
Patient 2 shows anterior segment dysgenesis and charac-
teristic craniofacial dysmorphism including maxillary
hypoplasia, and Patient 3 demonstrates anterior segment
dysgenesis. Taken together with the potential role of both
PITX2 (Karadeniz et al. 2004) and BMP4 (this paper) in
SHORT syndrome, these data strongly suggest involve-
ment of both factors in the same developmental processes.
This is supported by previous studies in animal models
which have shown that Bmp4 and Pitx2 act in a common
pathway in craniofacial/dental and left–right asymmetry
Fig. 3 a Intragenic BMP4
mutations and affected
pedigrees; mutation sites
indicated with arrows.
b Multiple sequence alignment
of BMP4 amino acid sequences
demonstrating conservation of
the histidine affected in the
identiﬁed H121R mutation.
Shaded areas indicate
conserved amino acids.
GenBank accession numbers are
as follows: Homo sapiens
NP_570911.2, Mus musculus
AAH34053, Danio rerio
AAH78423, Gallus gallus
NP_990568
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123development (Liu et al. 2003; Lu et al. 1999; St Amand
et al. 2000; Tsiairis and McMahon 2009). Speciﬁcally,
Pitx2 was shown to be a repressor of Bmp4 expression (Liu
et al. 2003; Lu et al. 1999), but Bmp4 was also able to
repress Pitx2 expression (St Amand et al. 2000).
The c.171dupC (p.E58RfsX17) mutation identiﬁed in
Patients 4 and 5 represents the most 50 nonsense mutation
reported to date and is expected to result in a complete loss
of function. This allele is likely to result in an absence of
protein product due to nonsense-mediated (NMD) decay of
the mutant mRNA since the stop codon associated with this
mutation is located more than 55 nt (152 nt) from the end
of the second to last exon (Holbrook et al. 2004; Khajavi
et al. 2006). If present, the mutated protein is predicted to
be 14% of its normal length and lack the transforming
growth factor beta (TGFb)-like domain and 91% of the
TGFb propeptide.
Our results further support the variable expressivity/
incomplete penetrance of BMP4 mutations, as has been
shown in previous publications (Bakrania et al. 2008;
Suzuki et al. 2009; Weber et al. 2008; Zhang et al. 2009).
While one previous family demonstrated a highly variable
phenotype in association with a frameshift mutation
(Bakrania et al. 2008), this is the ﬁrst report of a loss-of-
function mutation in an apparently unaffected parent
(mother of Patients 4 and 5). In addition, only one patient
in our group demonstrated digit anomalies and only one
had a brain anomaly, both commonly reported in previ-
ously described cases with deletion/nonsense mutations.
At the same time, new syndromes/features not described
in earlier reports, such as SHORT syndrome, poor growth,
macrocephaly, hydrocephalus, and diaphragmatic hernia,
were identiﬁed. In addition, the nonsense mutation
p.R198X, previously seen in a patient with cleft lip and
palate and no details about additional features (Suzuki
et al. 2009), was also seen in Patient 3 without cleft lip/
palate in our study. None of our patients or the previously
reported ocular cases demonstrated cleft lip/palate or
family history of colorectal cancer, which have been
previously reported in association with BMP4 alterations,
primarily missense mutations (Lubbe et al. 2011; Suzuki
et al. 2009).
The signiﬁcance of the p.H121R variant seen in Patient
5 in combination with the p.E58RfsX17 is unclear. The
histidine at position 121 is conserved (Fig. 3b), and the
variant was neither seen in 452 controls reported here nor
in 1,053 previously reported controls (Suzuki et al. 2009;
Lubbe et al. 2011). Interestingly, Patient 5, with two
mutations in BMP4, displays a milder ocular phenotype
(unilateral anophthalmia) than her half-sister with the
p.E58RfsX17 mutation only (bilateral anophthalmia), but
has more severe digit involvement (polydactyly vs. normal
hands/feet in Patient 4). Overall, the ocular and digit
phenotypes observed in these half-siblings are consistent
with the previously reported BMP4 spectrum, and there-
fore, it is difﬁcult to determine the contribution of the
p.H121R allele; it is possible that this variant represents a
rare polymorphism. The unaffected father of this patient
was not available for testing to determine whether the
allele was inherited from an unaffected parent or occurred
de novo.
A wide range of phenotypes have been reported in
association with various mutations in BMP4, ranging from
anomalies evident at birth to adult onset colorectal cancer.
Since Bmp4 has been shown to have various roles in
embryonic and adult tissues (Chang et al. 2001; Furuta and
Hogan 1998; Hogan 1996; Jiao et al. 2003; Solnica-Krezel
1999; Wordinger et al. 2007), its involvement in multiple
phenotypes is highly possible. Our data provide additional
support for loss-of-function BMP4 mutations to be asso-
ciated with syndromic ocular phenotypes. Each of the
probands reported here and all but one of the previously
reported cases with ocular phenotypes have mutations
which result in lack of functional protein product (deletion
or nonsense/frameshift mutations); in all but one of these
cases in which family members were tested, the mutation
was de novo or seen in affected family members only and
loss-of-function BMP4 mutations have never been reported
in control populations. In contrast, the majority of muta-
tions associated with cleft lip and palate, renal anomalies,
or colorectal cancer were missense mutations (Weber et al.
2008; Suzuki et al. 2009; Lubbe et al. 2011). While most of
the reported missense mutations were not seen in control
individuals and several modify conserved amino acids, in
more than half of the cases in which family members were
tested, the missense mutation was seen in an unaffected
relative (8 of 13). This suggests the possibility that some of
these missense variants represent rare polymorphisms
rather than pathogenic mutations. At the same time, the
number of rare BMP4 variants seen in patients with vari-
able phenotypes may suggest a contributory/sensitizing
role for BMP4 missense mutations leading to different
phenotypes depending on other genetic variants/mutations
present in the affected individuals. Additional mutational
screens and identiﬁcation of factors that may be involved in
modiﬁcation of the phenotypic expression of BMP4
mutations are needed to provide insight into the complexity
of human phenotypes associated with BMP4 genotypes.
The results of this study conﬁrm the role of BMP4 in
developmental ocular anomalies, particularly anophthal-
mia/microphthalmia and anterior segment defects, and
suggest that limb and brain anomalies may not be infor-
mative for determining which patients will beneﬁt from
molecular screening. Further screening for BMP4 muta-
tions/deletions in patients with SHORT syndrome and a
variety of ocular disorders will be important to further
502 Hum Genet (2011) 130:495–504
123deﬁne the range of anomalies associated with mutations in/
deletions of this gene.
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